Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis

被引:194
|
作者
Shawcross, D. L. [1 ,2 ]
Sharifi, Y. [2 ]
Canavan, J. B. [3 ,4 ]
Yeoman, A. D. [1 ,2 ]
Abeles, R. D. [1 ,2 ]
Taylor, N. J. [1 ,2 ]
Auzinger, G. [2 ]
Bernal, W. [1 ,2 ]
Wendon, J. A. [1 ,2 ]
机构
[1] Kings Coll Hosp London, Inst Liver Studies, Sch Med, Kings Coll London, London SE5 9RS, England
[2] Kings Coll Hosp London, Liver Intens Therapy Unit, London SE5 9RS, England
[3] Guys & St Thomass NHS Fdn Trust, NIHR Comprehens Biomed Res Ctr, London, England
[4] Kings Coll London, London, England
基金
美国国家卫生研究院;
关键词
Hepatic encephalopathy; Cirrhosis; Inflammation; Infection; Outcomes; INDUCED HYPERAMMONEMIA; BACTERIAL-INFECTION; PARTIAL-PRESSURE; BRAIN EDEMA; LIVER; NEUTROPHIL; ABNORMALITIES; HYPONATREMIA; PROGNOSIS; RATS;
D O I
10.1016/j.jhep.2010.07.045
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Patients with cirrhosis are prone to infection which is a frequent precipitant of hepatic encephalopathy (HE). Clinical studies have examined the importance of inflammation and infection in modulating the manifestation of symptoms of HE in acute liver failure and patients with cirrhosis and minimal/low grade HE. It would be logical to presume that this relationship persists in patients who develop severe HE in cirrhosis although this has not been examined to date. Methods: We report the findings of a prospective audit of 100 consecutive patients with cirrhosis admitted between Jan 2000 and March 2008 to a liver Intensive Care Unit (ICU) where HE was the primary indication for admission (59% Grade 3; 41% Grade 4). Haematological and microbiological data were collected at ICU admission, and organ scores and outcomes were recorded. Results: 46% of patients had positive cultures taken within 48 h from admission to ICU [25% blood] and a further 22% were culture negative but had evidence of systemic inflammation (SIRS). SIRS score (p = 0.03) and SOFA score (p = 0.006) were significantly higher in those patients with Grade 4 HE, who were also less likely to survive (p <0.001). HE grade/coma score did not correlate with ammonia, biochemistry or MELD score. Fifty-two percent of patients survived their ICU stay while the remainder developed progressive multiorgan failure and died; 38% survived to discharge, and 16% were transplanted. Conclusions: These data support an association between infection/SIRS and not ammonia, in patients with cirrhosis that develop severe HE. The presence or absence of infection/SIRS did not determine survival. (C) 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:640 / 649
页数:10
相关论文
共 50 条
  • [31] Association of serum albumin level with incidence and mortality of overt hepatic encephalopathy in cirrhosis during hospitalization
    Bai, Zhaohui
    Guo, Xiaozhong
    Tacke, Frank
    Li, Yingying
    Li, Hongyu
    Qi, Xingshun
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2019, 12
  • [32] Elevated serum neurofilament light chain levels are associated with hepatic encephalopathy in patients with cirrhosis
    Wang, Yan
    Xue, Yu-Feng
    Xu, Yi-Fan
    Wang, Ming-Wei
    Guan, Jing
    Chen, Xi
    METABOLIC BRAIN DISEASE, 2024, 39 (06) : 1099 - 1108
  • [33] Is sarcopenia associated with hepatic encephalopathy in liver cirrhosis? A systematic review and meta-analysis
    Chang, Ke-Vin
    Chen, Jin-De
    Wu, Wei-Ting
    Huang, Kuo-Chin
    Lin, Hong-Yi
    Han, Der-Sheng
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2019, 118 (04) : 833 - 842
  • [34] Ammonia Levels Do Not Guide Clinical Management of Patients With Hepatic Encephalopathy Caused by Cirrhosis
    Haj, Mona
    Rockey, Don C.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 (05): : 723 - 728
  • [35] A dynamic nomogram to predict transplant-free mortality in patients with hepatitis B-related cirrhosis and overt hepatic encephalopathy
    Shi, Ke
    Huang, Yunyi
    Zhang, Qun
    Ran, Chongping
    Hou, Jie
    Zhang, Yi
    Bi, Yufei
    Wang, Xianbo
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 108
  • [36] Glycerol Phenylbutyrate in Patients With Cirrhosis and Episodic Hepatic Encephalopathy: A Pilot Study of Safety and Effect on Venous Ammonia Concentration
    Ghabril, Marwan
    Zupanets, Igor A.
    Vierling, John
    Mantry, Parvez
    Rockey, Don
    Wolf, David
    O'Shea, Robert
    Dickinson, Klara
    Gillaspy, Heather
    Norris, Catherine
    Coakley, Dion F.
    Mokhtarani, Masoud
    Scharschmidt, Bruce F.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2013, 2 (03): : 278 - 284
  • [37] Establishment and evaluation of a model for predicting 3-month mortality in Chinese patients with hepatic encephalopathy
    Cui, Yanping
    Guan, Shan
    Ding, Jie
    He, Yukai
    Li, Qingfang
    Wang, Sikui
    Sun, Huiling
    METABOLIC BRAIN DISEASE, 2019, 34 (01) : 213 - 221
  • [38] Effect of proton pump inhibitors in hospitalization on mortality of patients with hepatic encephalopathy and cirrhosis but no active gastrointestinal bleeding
    Hung, Tsung-Hsing
    Lee, Hsing-Feng
    Tseng, Chih-Wei
    Tsai, Chih-Chun
    Tsai, Chen-Chi
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2018, 42 (04) : 353 - 359
  • [39] Development and Validation of a Prognostic Nomogram Based on Fibrosis-4 Index to Predict 3-Month Mortality in Patients with Hepatic Encephalopathy
    Guan, Yunxuan
    Liu, Kai
    Zhang, Xiujun
    Qi, Caoyan
    Chen, Xiaolu
    Zhang, Wenhui
    Chen, Yan
    Ma, Yu
    Pu, Lina
    Yuan, Jiahong
    Lu, Niansen
    Zhang, Chaochao
    Xue, Yuan
    HEPATITIS MONTHLY, 2023, 23 (01)
  • [40] Dynamic assessments of hepatic encephalopathy and ammonia levels predict mortality in acute-on-chronic liver failure
    Verma, Nipun
    Dhiman, Radha Krishan
    Choudhury, Ashok
    Taneja, Sunil
    Duseja, Ajay
    Singh, Virender
    Al Mahtab, Mamun
    Devarbhavi, Harshad
    Shukla, Akash
    Ning, Q.
    Hamid, Saeed Sadiq
    Butt, Amna Shubhan
    Jafri, Wasim
    Tan, Soek Siam
    Hu, Jinhua
    Zhongping, Duan
    Treeprasertsuk, Sombat
    Lee, Guan H.
    Ghazinyan, Hasmik
    Lesmana, Laurentius A.
    Sood, Ajit
    Midha, Vandana
    Goyal, Omesh
    Kim, Dong Joon
    Eapen, C. E.
    Goel, Ashish
    Tao, Han
    Shaojie, Xin
    Yuemin, Nan
    Dokmeci, A. Kadir
    Sahu, Manoj
    Singh, Ayaskanta
    Arora, Anil
    Kumar, Ashish
    Kumar, Ramesh
    Prasad, V. G. Mohan
    Shresta, Ananta
    Sollano, Jose
    Payawal, Diana Alcantara
    Shah, Samir
    Rao, P. N.
    Kulkarni, Anand
    Lau, George K.
    Sarin, Shiv Kumar
    HEPATOLOGY INTERNATIONAL, 2021, 15 (04) : 970 - 982